Atypical psoriasis following rituximab for rheumatoid arthritis.
Sarah A
SA
Hardcastle
Sam
S
Gibbs
Lyn
L
Williamson
D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D011565:Psoriasis / Q000175:diagnosis* / Q000209:etiology; D012008:Recurrence; D000069283:Rituximab; D012867:Skin / Q000473:pathology
D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab